| Name | AD4 |
|---|
| Description | AD4 is an artemisinin derivative that is a proteolytic targeting chimera (PROTAC) targeting PCLAF. AD4 can effectively degrade PCLAF in RS4;11 cells (IC50: 0.6 nM), thereby activating the p21/Rb axis and exerting anti-tumor activity. AD4 also prolonged survival of RS4;11-transplanted NOD/SCID mice, with in vivo efficacy[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.6 nM (PCLAF/KIAA0101)[1] |
| References |
| Molecular Formula | C55H78N4O15 |
|---|---|
| Molecular Weight | 1035.23 |